Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Responding to a Community's Concern: A Comparison of Breast Cancer Characteristics and Initial Treatment in Three Selected North Carolina Counties.

Vines AI, Carpenter WR, Chen RC, Cherry MW, Long DG, Amos KD, Godley PA.

N C Med J. 2017 Nov-Dec;78(6):357-365. doi: 10.18043/ncm.78.6.357.

2.

Transition to surgical residency: a multi-institutional study of perceived intern preparedness and the effect of a formal residency preparatory course in the fourth year of medical school.

Minter RM, Amos KD, Bentz ML, Blair PG, Brandt C, D'Cunha J, Davis E, Delman KA, Deutsch ES, Divino C, Kingsley D, Klingensmith M, Meterissian S, Sachdeva AK, Terhune K, Termuhlen PM, Mullan PB.

Acad Med. 2015 Aug;90(8):1116-24. doi: 10.1097/ACM.0000000000000680.

PMID:
25785673
3.

Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017.

McGuire KP, Hwang ES, Cantor A, Golshan M, Meric-Bernstam F, Horton JK, Nanda R, Amos KD, Forero A, Hudis CA, Meszoely I, De Los Santos JF.

Ann Surg Oncol. 2015 Jan;22(1):75-81. doi: 10.1245/s10434-014-3948-3. Epub 2014 Jul 25.

4.

Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.

Baker JJ, Meyers MO, Frank J, Amos KD, Stitzenberg KB, Ollila DW.

Am J Surg. 2014 Apr;207(4):549-54. doi: 10.1016/j.amjsurg.2013.04.012.

PMID:
24674829
5.

A pilot study of a home-based motivational exercise program for African American breast cancer survivors: clinical and quality-of-life outcomes.

Spector D, Deal AM, Amos KD, Yang H, Battaglini CL.

Integr Cancer Ther. 2014 Mar;13(2):121-32. doi: 10.1177/1534735413503546. Epub 2013 Oct 7.

PMID:
24105359
6.

Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.

Casbas-Hernandez P, D'Arcy M, Roman-Perez E, Brauer HA, McNaughton K, Miller SM, Chhetri RK, Oldenburg AL, Fleming JM, Amos KD, Makowski L, Troester MA.

Breast Cancer Res. 2013;15(5):R82.

7.

Competence and confidence with basic procedural skills: the experience and opinions of fourth-year medical students at a single institution.

Dehmer JJ, Amos KD, Farrell TM, Meyer AA, Newton WP, Meyers MO.

Acad Med. 2013 May;88(5):682-7. doi: 10.1097/ACM.0b013e31828b0007.

PMID:
23524922
8.

Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.

De Los Santos JF, Cantor A, Amos KD, Forero A, Golshan M, Horton JK, Hudis CA, Hylton NM, McGuire K, Meric-Bernstam F, Meszoely IM, Nanda R, Hwang ES.

Cancer. 2013 May 15;119(10):1776-83. doi: 10.1002/cncr.27995. Epub 2013 Feb 21.

9.

Relative value unit impact of complex skin closures to academic surgical melanoma practices.

Khandelwal CM, Meyers MO, Yeh JJ, Amos KD, Frank JS, Long P, Ollila DW.

Am J Surg. 2012 Sep;204(3):327-31. doi: 10.1016/j.amjsurg.2011.10.014.

PMID:
22920403
10.

Who teaches basic procedural skills: student experience versus faculty opinion.

Carr J, Deal AM, Dehmer J, Amos KD, Farrell TM, Meyer AA, Meyers MO.

J Surg Res. 2012 Oct;177(2):196-200. doi: 10.1016/j.jss.2012.05.084. Epub 2012 Jun 17.

PMID:
22818085
11.

Early recurrence in sentinel lymph node positive stage III melanoma patients.

Baker JJ, Ollila DW, Deal AM, Frank J, Amos KD, Meyers MO.

Am Surg. 2012 Jul;78(7):808-13.

PMID:
22748543
12.

Triple-negative breast cancer: an update on neoadjuvant clinical trials.

Amos KD, Adamo B, Anders CK.

Int J Breast Cancer. 2012;2012:385978. doi: 10.1155/2012/385978. Epub 2012 Jan 24.

13.

Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.

Román-Pérez E, Casbas-Hernández P, Pirone JR, Rein J, Carey LA, Lubet RA, Mani SA, Amos KD, Troester MA.

Breast Cancer Res. 2012 Mar 19;14(2):R51.

14.

Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples.

Elloumi F, Hu Z, Li Y, Parker JS, Gulley ML, Amos KD, Troester MA.

BMC Med Genomics. 2011 Jun 30;4:54. doi: 10.1186/1755-8794-4-54.

15.

Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.

Meyers MO, Klauber-Demore N, Ollila DW, Amos KD, Moore DT, Drobish AA, Burrows EM, Dees EC, Carey LA.

Ann Surg Oncol. 2011 Oct;18(10):2851-7. doi: 10.1245/s10434-011-1665-8. Epub 2011 Mar 26.

PMID:
21442348
16.

Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer.

Reeder-Hayes KE, Bainbridge J, Meyer AM, Amos KD, Weiner BJ, Godley PA, Carpenter WR.

Breast Cancer Res Treat. 2011 Aug;128(3):863-71. doi: 10.1007/s10549-011-1398-1. Epub 2011 Feb 22.

17.

The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation.

Carpenter WR, Reeder-Hayes K, Bainbridge J, Meyer AM, Amos KD, Weiner BJ, Godley PA.

Med Care. 2011 Feb;49(2):172-9. doi: 10.1097/MLR.0b013e3182028ff2.

18.

Age and Breslow depth are associated with a positive sentinel lymph node in patients with cutaneous melanocytic tumors of uncertain malignant potential.

Meyers MO, Yeh JJ, Deal AM, Byerly FL, Woosley JT, Frank J, Long PK, Amos KD, Ollila DW.

J Am Coll Surg. 2010 Dec;211(6):744-8. doi: 10.1016/j.jamcollsurg.2010.07.020.

PMID:
20869269
19.

Metastatic melanoma cells in the sentinel node cannot be ignored.

Ollila DW, Ashburn JH, Amos KD, Yeh JJ, Frank JS, Deal AM, Long P, Thomas ND, Meyers MO.

J Am Coll Surg. 2009 May;208(5):924-9; discussion 929-30. doi: 10.1016/j.jamcollsurg.2009.02.003.

PMID:
19476863
20.

Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.

Meyers MO, Yeh JJ, Frank J, Long P, Deal AM, Amos KD, Ollila DW.

Ann Surg Oncol. 2009 Apr;16(4):941-7. doi: 10.1245/s10434-008-0238-y. Epub 2008 Dec 20.

PMID:
19101766
21.

Impact of fellowships on surgical training.

Amos KD.

Bull Am Coll Surg. 2006 Jul;91(7):25-8. No abstract available.

PMID:
18551963
22.

Cancer-associated stromal fibroblasts promote pancreatic tumor progression.

Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD.

Cancer Res. 2008 Feb 1;68(3):918-26. doi: 10.1158/0008-5472.CAN-07-5714.

23.

Mammaglobin-A is a tumor-associated antigen in human breast carcinoma.

Tanaka Y, Amos KD, Fleming TP, Eberlein TJ, Goedegebuure PS.

Surgery. 2003 Jan;133(1):74-80.

PMID:
12563241
24.

Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes.

Tanaka Y, Amos KD, Joo HG, Eberlein TJ, Goedegebuure PS.

Int J Cancer. 2001 Nov;94(4):540-4.

Supplemental Content

Support Center